Emyria (ASX:EMD) wins digital health monitoring grant
“Openly — the core technology of this grant — will also support and monitor patients during our upcoming clinical trials. These pivotal studies will support the registration of our leading drug candidate EMD-003 - targeting unmet needs in psychological distress and the symptoms of anxiety, depression and stress,” said Dr Winlo.
https://themarketherald.com.au/emyria-asxemd-wins-digital-health-monitoring-grant-2021-02-05/?utm_content=buffer5f84c&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer+-+themarketherald
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.002(5.71%) |
Mkt cap ! $20.17M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.2¢ | $51.43K | 1.552M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 295884 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 1185025 | 2 |
View Market Depth
| Last trade - 15.59pm 21/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |